STAMFORD, Conn., Nov. 04, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is investigating Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”) on behalf of the Company’s investors.
The investigation seeks to determine whether Lyra’s board of directors has violated its fiduciary duty by instituting measures that impermissibly interfere with the ability of Lyra stockholders to elect directors of their choosing.
Lyra stockholders are encouraged to contact Abbott Cooper PLLC by calling (475) 333-0674, emailing ac@abbottlawyer.com or by filling out a contact from on our website at www.abbottlawyer.com for additional information about this investigation as well as their legal rights and options.
Abbott Cooper PLLC is dedicated to shareholders’ rights and empowering shareholders through strategic counsel and legal advocacy. For additional information about Abbott Cooper PLLC, please visit www.abbottlawyer.com.
CONTACT:
Abbott Cooper PLLC
Abbott Cooper
(475) 333-0674
www.abbottlawyer.com
Attorney advertising. Prior results do not guarantee a similar outcome.
Santa Clara, April 21, 2025 (GLOBE NEWSWIRE) -- Santa Clara, California - In recent developments,…
The Utility Token Debut to Boost Community Interaction, Exclusive Access, and Web3-Powered Gaming InnovationsDubai, UAE,…
CampervanHire.Com offers RV, camper van, and motorhome rentals for travelers.Stockport , April 21, 2025 (GLOBE…
Coginiti’s introduction of a digital twin delivers a real-time model of an enterprise solving the…
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in…
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in…
This website uses cookies.